Vaccines /

Saved in:
Bibliographic Details
Edition:4th ed.
Imprint:Philadelphia, Pa. : Saunders, c2004.
Description:xxi, 1662 p. : ill., maps ; 29 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/4999954
Hidden Bibliographic Details
Other authors / contributors:Plotkin, Stanley A., 1932-
Orenstein, Walter A.
ISBN:0721696880
Notes:Includes bibliographical references (p. 1635-1638) and index.
Also available on the Internet.
Table of Contents:
  • Acknowledgments
  • Contributors
  • Preface
  • Introduction
  • Chapter 1. A Short History of Vaccination
  • Chapter 2. The History of Polio Vaccine Development
  • Chapter 3. The Immunology of Vaccination
  • Chapter 4. The Vaccine Industry
  • Chapter 5. Vaccine Manufacturing
  • Chapter 6. Immunologic Adjuvants
  • Chapter 7. Vaccine Additives and Manufacturing Residuals in the United States--Licensed Vaccines
  • Chapter 8. General Immunization Practices
  • Chapter 9. Smallpox and Vaccinia
  • Chapter 10. Vaccination in the Immunocompromised Host
  • Chapter 11. Vaccination of Human Immunodeficiency Virus-Infected Persons
  • Vaccines Widely Used in Children and Adults
  • Chapter 12. Bacille Calmette-Guerin Vaccine
  • Chapter 13. Diphtheria Toxoid
  • Chapter 14. Haemophilus influenzae Vaccine
  • Chapter 15. Hepatitis A Vaccine
  • Chapter 16. Hepatitis B Vaccine
  • Chapter 17. Influenza Vaccine--Inactivated
  • Chapter 18. Influenza Vaccine--Live
  • Chapter 19. Measles Vaccine
  • Chapter 20. Mumps Vaccine
  • Chapter 21. Pertussis Vaccine
  • Chapter 22. Pneumococcal Polysaccharide
  • Chapter 23. Pneumococcal Conjugate Vaccine
  • Chapter 24. Poliovirus Vaccine--Inactivated
  • Chapter 25. Poliovirus Vaccine--Live
  • Chapter 26. Rubella Vaccine
  • Chapter 27. Tetanus Toxoid
  • Chapter 28. Varicella Vaccine
  • Chapter 29. Combination Vaccines
  • Vaccines for Special Circumstances
  • Chapter 30. Adenovirus Vaccine
  • Chapter 31. Anthrax Vaccine
  • Chapter 32. Cholera Vaccine
  • Chapter 33. Japanese Encephalitis Vaccines
  • Chapter 34. Meningococcal Vaccines
  • Chapter 35. Miscellaneous Limited-Use Vaccines
  • Chapter 36. Plague
  • Chapter 37. Rabies Vaccine
  • Chapter 38. Tick-Borne Encephalitis Virus Vaccine
  • Chapter 39. Typhoid Fever Vaccine
  • Chapter 40. Yellow Fever Vaccine
  • Selected Vaccines of the Future
  • Chapter 41. Technologies for Making New Vaccines
  • Chapter 42. Cytomegalovirus and Herpes Simplex Vaccines
  • Chapter 43. Diarrheal Disease Vaccines
  • Chapter 44. Human Immunodeficiency Virus
  • Chapter 45. Human Papillomavirus Vaccine for Cervical Cancer Prevention
  • Chapter 46. Lyme Disease Vaccine
  • Chapter 47. Malaria Vaccine
  • Chapter 48. Parasitic Disease Vaccines
  • Chapter 49. Poxviruses as Immunization Vehicles
  • Chapter 50. Respiratory Syncytial Virus Vaccine
  • Chapter 51. Rotavirus Vaccine
  • Chapter 52. Staphylococcus Vaccine
  • Public Health and Regulatory Issues
  • Chapter 53. Immunization in the United States
  • Chapter 54. Immunization in Europe
  • Chapter 55. Vaccination Programs in Developing Countries
  • Chapter 56. Community Immunity
  • Chapter 57. Economic Analyses of Vaccine Policies
  • Chapter 58. Vaccines for International Travel
  • Chapter 59. Vaccines for Health Care Workers
  • Chapter 60. Regulation and Testing of Vaccines
  • Chapter 61. Safety of Immunizations
  • Chapter 62. Multiple Vaccines and the Immune System
  • Chapter 63. Legal Issues
  • Appendix 1. Recommendations of the Advisory Committee on Immunization Practices
  • Appendix 2. Immunobiologicals and Their Manufacturers and Distributors
  • Appendix 3. Representative Vaccine Information Statement
  • Appendix 4. Case Definitions for Selected Vaccine-Preventable Diseases Under Public Health Surveillance in the United States
  • Appendix 5. Web Sites that Contain Information About Immunization
  • List of Previous Authors
  • Index